LATEST NEWS & INSIGHTS
from nina capital & companies
2021 news
CONTEXTFLOW.
Sep 16, 2021
Wellbeing to integrate Contextflow's clinical decision-support tool.
SUBTLE MEDICAL.
Sep 14, 2021
Aidoc and Subtle Medical partner to bring end-to-end AI solutions to medical imaging.
REPLICA ANALYTICS.
Aug 17, 2021
Ottawa's Replica Analytics using 'synthetic data' to ease medical researchers' pain points.
ULTROMICS.
Aug 15, 2021
Ultromics Raises $33M in Series B Funding to Help Transform Cardiac Disease Treatment.
NINA CAPITAL.
Jul 29, 2021
THCB Spotlights: Marta Zanchi, Founder & Managing Partner at Nina Capital.
NINA CAPITAL.
Jul 27, 2021
Health Tech Venture Capital Firm Nina Capital Announces Five More Investments and Launches Second Fund Set to Reach EUR40 Million ($47.4 Million).
ZETTA GENOMICS.
Jul 14, 2021
Future Perfect and Zetta Genomics win contract to solve data management challenges for the East Genomics Laboratory Hub.
KHEIRON MEDICAL.
Jul 13, 2021
Europe’s 17 healthtech startups to watch, according to top healthtech founders.
ELYPTA.
Jun 28, 2021
Pioneering the profiling of glycosaminoglycans in early cancer detection.
KHEIRON.
Jun 23, 2021
Artificial intelligence can be used to read mammograms as efficiently as radiologists.
PLENOPTIKA.
Jun 20, 2021
QuickSee handheld autorefractor can dramatically increase access to eyeglasses, study finds.
SUBTLE MEDICAL.
Jun 17, 2021
Capstone Health Alliance Announces Partnership with Subtle Medical for Improved PET and MRI Imaging.
KHEIRON.
Jun 13, 2021
Kheiron's AI breast screening solution Mia® receives regulatory clearance in Australia and New Zealand.
NEURESCUE.
Jun 9, 2021
Neurescue's Breakthrough Intelligent Balloon Catheter FDA 510(k) Cleared for Hemorrhage Control and IDE Approved for Cardiac Arrest.
SUBTLE MEDICAL.
Jun 8, 2021
Subtle Medical Receives CE Mark for SubtlePET™ 2.0 to Expand Improved PET Imaging Capabilities.
REPLICA ANALYTICS.
Jun 1, 2021
Replica Analytics and Euris Launch Cloud-Based Data Synthesis Platform.
MOVEUP.
May 26, 2021
MoveUP secures €3.65 million in European financing round to support its domestic scale-up and international expansion.
REPLICA ANALYTICS.
May 25, 2021
New Partnership Between Aridhia and Replica Analytics Powers Rapid, Secure and Compliant Use of Health Data.
EARLYSIGHT.
May 25, 2021
Geneva-based EarlySight lands €2 million for its eye diseases diagnostic tool.
ULTROMICS.
May 17, 2021
AI Able to Predict COVID-19 Mortality From Cardiac Ultrasound Measurements.
SUBTLE MEDICAL.
May 5, 2021
Subtle Medical Awarded Breakthrough Patent for Reduced Contrast Agent Dosage in Medical Imaging Exams.
NINA CAPITAL.
Apr 14, 2021
Nina Capital makes the list of "Notable Investors in European Healthtech" in Dealroom's Digital Healthcare: Patient-First report.
SEGMED.
Apr 2, 2021
Segmed, Inc. named one of The Startup Pill Fastest Growing Innovative Artificial Intelligence Startups of 2020.
NINA CAPITAL.
Mar 30, 2021
Aldea Ventures creates ‘hybrid’ European €100M fund to invest both in micro VCs, plus follow-on.
SUBTLE MEDICAL.
Mar 9, 2021
Subtle Medical Launches SubtleMR 2.0 to Expand Improved MRI Capabilities.
NEURESCUE.
Mar 3, 2021
Neurescue Announces Appointment of Medtronic Veteran Mette-Marie Harild to Company’s Board of Directors.
ELYPTA.
Feb 25, 2021
Start-Up Spotlight: Elypta Targets World’s First Metabolism-Based Early Cancer Diagnosis.
SARCURA.
Feb 23, 2021
Sarcura and imec to collaborate on high throughput cytometry solution for automated (T-)cell separation, tackling manufacturing challenges of cell and gene therapies.
ELYPTA.
Jan 28, 2021
Elypta granted US patent for its liquid biopsy method based on cancer metabolism.
ULTROMICS.
Jan 5, 2021
FDA Clears Ultromics Echocardiography AI for Auto Identification of Coronary Artery Disease.
ULTROMICS.
Jan 5, 2021
Ultromics receives FDA Clearance for a first-of-kind solution in Echocardiography to help clinicians diagnose disease.
SEGMED.
Jan 1, 2021
A Secured Cloud-Based Platform That Provides A One-Stop Shop Solution For Medical AI Companies.
TERAPET.
Dec 31, 2020
Terapet together with their world class R&D partners (CERN, Karolinska Institute and Skandion Clinic) are awarded a total of CHF 1’530’000 non-dilutive funds.
